Actualités Scancell Holdings Plc - SCLP | Actions London Stock Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

IN BRIEF: Scancell hurt by revaluation of derivative liability loss

PLC - Oxford, UK-based pharmaceutical firm - Pretax loss multiplies to GBP13.8 million in the six months to October 3 ...

Scancell Holdings Plc Interim Results

Scancell Holdings Plc 30 January 2025 30 January 2025 Scancell Holdings plc ("Scancell" or the "Company") Interim Results for the six...

Scancell Holdings Plc Notice of Interim Results

Scancell Holdings Plc 23 January 2025 Scancell Holdings plc ("Scancell" or the "Company") Notice of Interim Results Scancell Holdings...

Scancell encouraged by early results in cancer vaccine trial

Scancell Holdings PLC on Thursday said its cancer vaccine had achieved early validation for clinical use. The Oxfor ...

Scancell Holdings Plc Modi-1 Vaccine Achieves Early Clinical Validation

Scancell Holdings Plc 09 January 2025 9 January 2025 Scancell Holdings plc ("Scancell" or the "Company") Scancell's Modi-1 Moditope®...

Scancell Holdings Plc Result of Retail Offer and Total Voting Rights

Scancell Holdings Plc 09 December 2024 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO...

IN BRIEF: Scancell funded deep into 2026 as raises GBP10 million

PLC - Oxford, England-based developer of immunotherapies - Raises GBP10.3 million from the placing and direct subscri ...

Scancell Holdings Plc Result of Placing and Subscription

Scancell Holdings Plc 05 December 2024 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO...

Scancell Holdings Plc Retail Offer for up to £1 million

Scancell Holdings Plc 04 December 2024 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR...

Scancell Holdings Plc Proposed fundraise in excess of £8.5 million

Scancell Holdings Plc 04 December 2024 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO...

Scancell Holdings Plc Second Commercial License Agreement with Genmab

Scancell Holdings Plc 04 December 2024 4 December 2024 Scancell Holdings plc ("Scancell" or the "Company") Scancell Announces Genmab...

Scancell announces promising findings from cancer drug trial

Scancell Holdings PLC on Monday reported positive data from an ongoing trial on patients receiving a treatment combin ...

Scancell Holdings Plc Positive data from Phase 2 SCOPE trial with SCIB1

Scancell Holdings Plc 18 November 2024 18 November 2024 Scancell Holdings plc ("Scancell" or the "Company") Scancell announces further...

EXECUTIVE CHANGES: New Scancell, Nanoco and LPA CEOs; Coral CEO exits

The following is a round-up of London-listed company director and manager changes announced this week and not separat ...

Scancell Holdings Plc Result of Annual General Meeting

Scancell Holdings Plc 25 October 2024 25 October 2024 Scancell Holdings plc ("Scancell" or the "Company") Result of Annual General Meeting...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Scancell Holdings Plc (SCLP)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

SCLP Actualités

IN BRIEF: Scancell hurt by revaluation of derivative liability loss

Scancell Holdings Plc Interim Results

Scancell Holdings Plc Notice of Interim Results

Scancell encouraged by early results in cancer vaccine trial

Scancell Holdings Plc Modi-1 Vaccine Achieves Early Clinical Validation

Scancell Holdings Plc Result of Retail Offer and Total Voting Rights

IN BRIEF: Scancell funded deep into 2026 as raises GBP10 million

Scancell Holdings Plc Result of Placing and Subscription

Scancell Holdings Plc Retail Offer for up to £1 million

Scancell Holdings Plc Proposed fundraise in excess of £8.5 million

Scancell Holdings Plc Second Commercial License Agreement with Genmab

Scancell announces promising findings from cancer drug trial

Scancell Holdings Plc Positive data from Phase 2 SCOPE trial with SCIB1

EXECUTIVE CHANGES: New Scancell, Nanoco and LPA CEOs; Coral CEO exits

Scancell Holdings Plc Result of Annual General Meeting

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Scancell Holdings Plc (SCLP) Actualités

Scancell Holdings Plc (SCLP)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

SCLP Actualités

IN BRIEF: Scancell hurt by revaluation of derivative liability loss

Scancell Holdings Plc Interim Results

Scancell Holdings Plc Notice of Interim Results

Scancell encouraged by early results in cancer vaccine trial

Scancell Holdings Plc Modi-1 Vaccine Achieves Early Clinical Validation

Scancell Holdings Plc Result of Retail Offer and Total Voting Rights

IN BRIEF: Scancell funded deep into 2026 as raises GBP10 million

Scancell Holdings Plc Result of Placing and Subscription

Scancell Holdings Plc Retail Offer for up to £1 million

Scancell Holdings Plc Proposed fundraise in excess of £8.5 million

Scancell Holdings Plc Second Commercial License Agreement with Genmab

Scancell announces promising findings from cancer drug trial

Scancell Holdings Plc Positive data from Phase 2 SCOPE trial with SCIB1

EXECUTIVE CHANGES: New Scancell, Nanoco and LPA CEOs; Coral CEO exits

Scancell Holdings Plc Result of Annual General Meeting

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités